Roche Diabetes Care’s Michael Goetzl explains how the company is spearheading a combined digital-pharmaceutical approach to diabetes and how pharma firms can best embrace holistic strategies.
Brett Lewis, general manager of Roche Diabetes Care UK and Ireland, said: "I’m delighted to be embarking on this important research programme with Ieso, whose pioneering cognitive and ...
The complaint was filed on behalf of Roche Diabetes Care Inc., Roche Diabetes Care GmbH and Hoffmann-La Roche Inc, by ...
Roche ROG-1.53%decrease; red down pointing triangle confirmed its profit outlook for the year after its eye drug Vabysmo, multiple-sclerosis treatment Ocrevus and hemophilia injection Hemlibra ...
Roche CEO: not good to limit competition in ... Executives at Eli Lilly (LLY.N), opens new tab, Novo's main rival in the obesity and diabetes drug market, have repeatedly voiced concerns over ...
1 Day ROG -1.02% DJIA 0.59% S&P 500 0.38% Health Care/Life Sciences 2.54% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
Swiss Pharmaceutical giant Roche Holding (OTCQX:RHHBY) (OTCQX:RHHBF) on Wednesday reaffirmed its full-year sales and earnings outlook after the company’s third-quarter sales results exceeded ...
Brian Roche co-anchors News 8 at 5 p.m. each weekday. He is also the 8 On Your Side Consumer/Investigative reporter for News 8. Brian is an Emmy Award winning anchor and reporter. He has been ...
An experimental Alzheimer’s therapy from Roche successfully cleared a protein ... since demand for its blockbuster weight loss and diabetes drugs began booming, STAT says. Lilly said sales ...
A multi-institutional group of researchers led by the Hubrecht Institute and Roche's Institute of Human Biology has developed strategies to identify regulators of intestinal hormone secretion.
getting an accurate and timely diagnosis is critical to providing the best care for patients and curbing transmission,” said Matt Sause, CEO of Roche Diagnostics. “Using TAGS technology ...
Jain covers the Healthcare sector, focusing on stocks such as AstraZeneca, Novo Nordisk, and Roche Holding AG ... The company operates through two segments, including Diabetes & Obesity Care, and ...